Navigation Links
Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
Date:7/30/2008

laxoSmithKline (GSK).

The Company reported a net loss for the quarter ended June 30, 2008 of $74.2 million ($0.55 per share), compared with a net loss for the second quarter of 2007 of $51.3 million ($0.38 per share). The increased net loss for the quarter was due primarily to increased research and development costs related to the progress of LymphoStat-B Phase 3 trials, in addition to increased ABthrax manufacturing costs for production required to initiate delivery to the Strategic National Stockpile under the Company's agreement with the U.S. Government.

For the six months ended June 30, 2008, HGS reported increased revenues of $23.8 million, compared with revenues of $18.3 million for the same period of the previous year. Revenues included $17.7 million recognized from the Albuferon agreement and $3.3 million recognized from the LymphoStat-B agreement.

The Company reported a net loss of $121.1 million ($0.90 per share) for the six months ended June 30, 2008, compared with a net loss of $102.3 million ($0.76 per share) for the same period of the previous year. The increased net loss for the six months was due primarily to increased research and development costs related to LymphoStat-B Phase 3 trials and the Company's oncology portfolio, including HGS-ETR1 and HGS1029, in addition to increased ABthrax manufacturing costs. These costs were partially offset by a one-time gain resulting from the sale of CoGenesys, Inc. stock to Teva Pharmaceutical Industries, Ltd.

Net cash burn for the six months ended June 30, 2008 totaled $113.1 million. (For information on the calculation of this non-GAAP financial measure, visit http://www.hgsi.com/images/Q2results/netcashburn.pdf ) As of June 30, 2008, cash and investments totaled $539.3 million, of which $466.8 million is unrestricted and available for operations. This compares with cash and investments totaling $603.8
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
2. Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
3. New map IDs the core of the human brain
4. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
5. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
6. China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
7. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
8. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
9. Robots moving closer to humans
10. Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes
11. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... new work by a Florida State University research team ... take your temperature, emit white light, and convert photon ... looks like a butterfly. , Biwu Ma, associate professor ... the FAMU-FSU College of Engineering, created the molecule in ... to discover that his creation has many other unique ...
(Date:8/28/2014)... Earlier this month, a report was ... the U.S. Air Force on the performance of vehicles ... this type of fuel made from mustard seeds, offered ... to America’s Eco friendly future. In fact, every branch ... become independent of foreign oil over the next few ...
(Date:8/28/2014)... 2014 Whitehouse Laboratories is excited to ... with PTI Inspection Systems that will enable ... the art leak testing method development and validation programs ... available. As part of this agreement, Whitehouse Labs has ... Detection Instrument developed and manufactured by PTI. The ...
(Date:8/27/2014)... , Aug. 27, 2014 Rhythm, a biopharmaceutical ... genetic deficiencies that result in metabolic disorders, announced today ... S-1 with the U.S. Securities and Exchange Commission (SEC) ... of its common stock. The number of shares to ... have not yet been determined. Citigroup and ...
Breaking Biology Technology:Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2
... 24 Lixte,Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) ... Over-The-Counter Bulletin Board under,the Symbol LIXT. Commenting on ... stated, "We believe that being a publicly traded company ... available to us as,a private company. Having access to ...
... BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced ... Sciences Conference in New York. A live webcast ... at 2:00 p.m. Eastern,Time may be accessed at ... be archived for seven days. (Logo: ...
... OXFORD, England, September 24 ProImmune Ltd., a leading,provider ... and,services for antigen discovery, has announced the launch of ... adding to the series of,discovery services for Class I ... II REVEAL(TM) binding assay for HLA alleles DR1-4, is ...
Cached Biology Technology:Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT 2Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT 3Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT 4BioCryst to Present at UBS 2007 Global Life Sciences Conference 2BioCryst to Present at UBS 2007 Global Life Sciences Conference 3ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles 2
(Date:8/28/2014)... an expansion of marine protected areas is needed to ... According to investigators from the Wildlife Conservation Society and ... on saving the largest numbers of species, often at ... difficult-to-replace ecological functions. , Many vital ecological ... that also are food for millions of people. ...
(Date:8/28/2014)... Access to Research Careers) Program has announced the travel ... from October 18 22, 2014 in San Diego, ... entry of students, post doctorates and scientists from underrepresented ... and to encourage the participation of young scientists at ... MARC conferred 16 awards totaling $29,600., The FASEB MARC ...
(Date:8/28/2014)... MARC (Maximizing Access to Research Careers) Program has ... Society of America,s 27th Annual Mouse Molecular Genetics ... in Pacific Grove, California. These awards are ... doctorates and scientists from underrepresented groups into the ... encourage the participation of young scientists at the ...
Breaking Biology News(10 mins):Study finds marine protected areas inadequate for protecting fish and ocean ecology 2
... recent study, published in the open access Journal ... on the activity and distribution of the bee species ... examine its association with the invasive creeping daisy Sphagneticola ... daisy could in fact have a positive influence on a ...
... D.C. October 25, 2013 -- One of the keys to healthful ... glucose (sugar) levels to ensure they remain at stable levels. People ... that read sugar levels in a tiny drop of blood. ... non-invasive way to make monitoring easier. Using infrared laser light applied ...
... This news release is available in German ... cancer patient embarks on a course of treatment, tests can ... cytostatic agent combination is likely to be effective. But the ... their widespread use. Collaborating with DITABIS Digital Biomedical Imaging Systems ...
Cached Biology News:Angel or demon: Can a potentially invasive plant bring a positive influence to a region? 2Measuring blood sugar with light 2A cost-effective way toward personalized cancer drugs 2A cost-effective way toward personalized cancer drugs 3
... Cap tool provides the firm pressure ... caps in tubes or plates. The ... end that firmly holds thin-wall 0.5 ... when opening or closing. A side ...
... Pulser Xcell microbial system, 100 to ... for electroporation of bacterial and fungal ... unit, PC module for exponential decay ... cuvettes (5 each of 0.1 and ...
... solution. In PBS containing ... other proprietary stabilizers; 0.2 ... to stabilize activity of ... at high conjugate dilutions ...
... The Gene Pulser Xcell eukaryotic ... 50-60 Hz, is used for ... system includes the main unit, ... microfarad range) or square-wave pulses, ...
Biology Products: